Emerging data have shown that proprotein convertase subtilisin/kexin type 9 (PCSK9), a key protein in lipid metabolism, is involved in the production of inflammatory cytokines, endothelial dysfunction, atherosclerotic plaque development, rupture and subsequent atherothrombosis, leading to acute cardiovascular events [2]. This evidence concerns the gene PCSK9 and endothelial dysfunction.